Blog
Article
We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for programs to communicate with underrepresented and marginalized populations.
![[MINI-PODCAST] Ep 51: Cultural Humility & Sensitivity](https://cdn.sanity.io/images/0vv8moc6/accc-cancer/e52f62d96de86fa1b1ad05b759bede599c0b88fd-508x508.png?fit=crop&auto=format)
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
From unethical experimentation to systematic exclusion, racism has played a terrible role in the development of American healthcare. On this mini-podcast, we discuss how the legacy of clinical trials continues to affect today’s research, and share strategies for cancer programs to effectively communicate with underrepresented and marginalized populations.
Guest: Christopher Lathan, MD, MS, MPH, Medical Director, Dana-Farber Cancer Institute at St. Elizabeth's Medical Center; Associate Medical Director, DFCI Network
Related Content: